Therapeutic Decision Based on Molecular Detection of Resistance Mechanism in an ALK-rearranged Lung Cancer Patient: A Case Report

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s184745
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Molecular Mechanisms of Resistance to First- And Second-Generation ALK Inhibitors in ALK-rearranged Lung Cancer

European Journal of Cancer
Cancer ResearchOncology
2016English

Alectinib Resistance in ALK-rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Serial Liquid Biopsies for Detection of Treatment Failure and Profiling of Resistance Mechanisms in KLC1-ALK Rearranged Lung Cancer

Cold Spring Harbor molecular case studies
BiochemistryMolecular MedicineGenetics
2019English

Complete Pathological Response to Crizotinib in a Patient With ALK-rearranged Lung Adenocarcinoma

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

Miliary Brain Metastases in a Patient With ROS1-Rearranged Lung Adenocarcinoma: A Case Report

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

The Treatment Choice Based on Radiographic Features for Metastatic Brain Tumors in ALK-Rearranged Non–small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

A Heterochronic Genetic Change From an EGFR Mutation to an ALK Rearrangement in a Patient With Lung Adenocarcinoma: A Case Report

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

A Case Report of an EML4-ALK-positive Elderly Non-Small Cell Lung Cancer Patient With a Poor PS Successfully Treated With Crizotinib

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2013English

A Case of ALK- Rearranged Adenocarcinoma With Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy